Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Total Assets : ¥1,938 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Total Assets?

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥1,938 Mil.

Warning Sign:

If a company builds assets at 20.7% a year, faster than its revenue growth rate of 9% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's average Total Assets Growth Rate was 10.70% per year. During the past 3 years, the average Total Assets Growth Rate was 21.40% per year. During the past 5 years, the average Total Assets Growth Rate was 20.70% per year.

During the past 8 years, Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 42.50%. The lowest was 21.40%. And the median was 24.40%.

Total Assets is connected with ROA %. Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 was 2.04%. Total Assets is also linked to Revenue through Asset Turnover. Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.68.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Total Assets Historical Data

The historical data trend for Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Total Assets Chart

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

746.67

844.65

1,187.07

1,591.62

1,687.07

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															1,615.01	1,515.51	1,625.29	1,687.07	1,938.43

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	856.042	+	831.023
	=	1,687

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	863.264	+	1075.166
	=	1,938

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Total Assets Explanation

Total Assets is connected with ROA %.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	36.904	/	( (1687.065	+	1938.43)	/ 2 )
	=	36.904	/	1812.7475
	=	2.04 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	1237.408	/	( (1687.065	+	1938.43)	/ 2 )
=	1237.408	/	1812.7475
=	0.68

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

No. 18, Youlian 1st Street, 13th Floor, Jinniu District, Sichuan Province, Chengdu, CHN, 610081

Website

https://www.hezongyy.com

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd provides convenient, efficient and low-cost medical circulation services for the vast community medical terminals and primary medical institutions. It offers various products such as respiratory system, cardiovascular and neurological drugs, biological product, rheumatism and bone injuries and other medicines, cardiovascular and neurological drugs and others.

Executives

Tian Wen Shu	Supervisors
Ai Ying Ping	Director
Lei Qi Gang	Executives
Hao Rui Zhi	Directors, Directors, and Executives

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Headlines

No Headlines